TAMOXIFEN - 17 Annonces

Friday 18 July 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Friday 18 July 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Thursday 17 July 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Thursday 17 July 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Saturday 28 June 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Saturday 28 June 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Wednesday 11 June 2025

Quantité : 1kg; 25kg;

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Wednesday 11 June 2025

Quantité : 1kg; 25kg;

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Wednesday 11 June 2025

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Wednesday 11 June 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Saturday 07 June 2025

Quantité : 1kg; 25kg;

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Saturday 07 June 2025

Quantité : 1kg; 25kg;

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Tuesday 20 May 2025

Quantité : 10 TONS

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Tuesday 20 May 2025

Quantité : 10 TONS

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Tuesday 20 May 2025

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...

Tuesday 08 April 2025

Quantité : 9999 - Prix : 1,00 €

Tamoxifen is a nonsteroidal estrogen antagonist of interest in the treatment of some forms of breast cancer. It is a Protein Kinase C inhibitor, and induces apoptosis in human malignant glioma cell lines. In breast cancer, the gene repressor activity of tamoxifen against ERBB2 is...

Tuesday 08 April 2025

Quantité : 9999 - Prix : 1,00 €

Tamoxifen citrate is a non-steroidal compound with structural similarities to diethylstilbestrol. Tamoxifen citrate is an estrogen receptor antagonist/partial agonist. Induces oxidative stress and apoptosis in estrogen receptor-negative cancer cell lines. Displays neuroprotective...